HealthStream (HSTM) to Release Earnings on Monday

HealthStream (NASDAQ:HSTM) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Monday, August 4th. Analysts expect the company to announce earnings of $0.16 per share and revenue of $74.39 million for the quarter. HealthStream has set its FY 2025 guidance at EPS.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, May 5th. The technology company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The firm had revenue of $73.49 million during the quarter, compared to analysts’ expectations of $74.93 million. HealthStream had a return on equity of 5.36% and a net margin of 6.54%. During the same quarter last year, the business earned $0.17 EPS. On average, analysts expect HealthStream to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

HealthStream Price Performance

Shares of HSTM stock opened at $25.65 on Friday. The firm has a market capitalization of $782.97 million, a price-to-earnings ratio of 40.71, a price-to-earnings-growth ratio of 3.38 and a beta of 0.42. The business has a fifty day moving average of $27.35 and a 200 day moving average of $30.26. HealthStream has a 1 year low of $25.36 and a 1 year high of $34.24.

HealthStream Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Monday, May 19th were paid a $0.031 dividend. The ex-dividend date was Monday, May 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is 19.05%.

HealthStream declared that its Board of Directors has initiated a share buyback program on Thursday, May 8th that permits the company to repurchase $25.00 million in shares. This repurchase authorization permits the technology company to reacquire up to 3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Institutional Investors Weigh In On HealthStream

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in HealthStream by 15.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 54,354 shares of the technology company’s stock valued at $1,749,000 after buying an additional 7,211 shares in the last quarter. Royal Bank of Canada increased its holdings in HealthStream by 194.2% in the 1st quarter. Royal Bank of Canada now owns 43,899 shares of the technology company’s stock valued at $1,413,000 after purchasing an additional 28,977 shares during the last quarter. Finally, Jane Street Group LLC acquired a new stake in HealthStream in the 1st quarter valued at approximately $1,532,000. 69.58% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reduced their target price on HealthStream from $30.00 to $29.00 and set a “hold” rating for the company in a research note on Thursday, May 15th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HealthStream currently has an average rating of “Moderate Buy” and an average price target of $31.50.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.